Notes - Finance Income And Finance Costs

ONO PHARMACEUTICAL CO., LTD. - Filing #7242262

Concept 2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
Notes - Finance income and finance costs
Components of finance income and finance costs
Finance income
Interest income
Financial assets measured at amortized cost
1,582,000,000 JPY
1,119,000,000 JPY
Gain on investments in securities
Financial assets measured at fair value through profit or loss
49,000,000 JPY
JPY
Other
93,000,000 JPY
105,000,000 JPY
Finance income
4,774,000,000 JPY
4,027,000,000 JPY
Finance costs
Interest expenses
Financial liabilities measured at amortized cost
1,178,000,000 JPY
0 JPY
Other
227,000,000 JPY
13,000,000 JPY
Finance costs
5,318,000,000 JPY
229,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.